InflammaPark PROJECT

FRRB Project 1750818 - Decoding the molecular basis of the interplay between neuroinflammation and neurodegeneration in Parkinson’s disease

Name and Surname of PI

Simone Bido

Project Acronym

InflammaPark

Project ID

1750818

Host Institution

IRCCS Ospedale San Raffaele - Milan

Pathology of Interest

Parkinson's Disease

Research Area

Neurology

Project Start Date

1 May 2021

Project End Date

30 April 2024

Funding

€ 575.420,00

Type of Project

Individual

PROJECT SUMMARY

Parkinson’s disease affects about the 1% of the population over 60 worldwide, with no negligible cases in the group of population of 30-60 years old. Like in other diseases, inflammation seems to have a crucial role in Parkinson’s disease development. The objective of this project is to describe the molecular mechanisms by which the inflammatory process is able to elicit and sustain the degeneration of the dopaminergic neurons (the most affected in Parkinson’s disease). To achieve this result, we will take advantage from advanced technics of molecular investigation, which enable the detailed analysis of the data collected from ad hoc animal models and human biological samples from parkinsonian patients. These findings will allow us to devise pharmacological and genetic treatments suitable to mitigate and block the disease progression together with the identification of possible molecular markers for an early-stage diagnosis.